{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:46:22Z","timestamp":1743155182078,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":60,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071627877"},{"type":"electronic","value":"9781071627884"}],"license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2788-4_3","type":"book-chapter","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T13:04:40Z","timestamp":1666098280000},"page":"27-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC\/Transcriptional Repressor Complexes"],"prefix":"10.1007","author":[{"given":"Roland","family":"Windisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Kreissig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"issue":"15","key":"3_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1056\/NEJMc1308782","volume":"369","author":"CA Miller","year":"2013","unstructured":"Miller CA, Wilson RK, Ley TJ (2013) Genomic landscapes and clonality of de novo AML. N Engl J Med 369(15):1473. https:\/\/doi.org\/10.1056\/NEJMc1308782","journal-title":"N Engl J Med"},{"issue":"1","key":"3_CR2","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","volume":"11","author":"K Morita","year":"2020","unstructured":"Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, Kuipers J, Loghavi S, Wang SA, Yan Y, Furudate K, Matthews J, Little L, Gumbs C, Zhang J, Song X, Thompson E, Patel KP, Bueso-Ramos CE, DiNardo CD, Ravandi F, Jabbour E, Andreeff M, Cortes J, Bhalla K, Garcia-Manero G, Kantarjian H, Konopleva M, Nakada D, Navin N, Beerenwinkel N, Futreal PA, Takahashi K (2020) Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun 11(1):5327. https:\/\/doi.org\/10.1038\/s41467-020-19119-8","journal-title":"Nat Commun"},{"issue":"5","key":"3_CR3","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","volume":"100","author":"DG Gilliland","year":"2002","unstructured":"Gilliland DG, Griffin JD (2002) The roles of FLT3 in hematopoiesis and leukemia. Blood 100(5):1532\u20131542. https:\/\/doi.org\/10.1182\/blood-2002-02-0492","journal-title":"Blood"},{"issue":"6669","key":"3_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/35901","volume":"391","author":"F Grignani","year":"1998","unstructured":"Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391(6669):815\u2013818. https:\/\/doi.org\/10.1038\/35901","journal-title":"Nature"},{"issue":"6","key":"3_CR5","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/sj.emboj.7600593","volume":"24","author":"S Racanicchi","year":"2005","unstructured":"Racanicchi S, Maccherani C, Liberatore C, Billi M, Gelmetti V, Panigada M, Rizzo G, Nervi C, Grignani F (2005) Targeting fusion protein\/corepressor contact restores differentiation response in leukemia cells. EMBO J 24(6):1232\u20131242. https:\/\/doi.org\/10.1038\/sj.emboj.7600593","journal-title":"EMBO J"},{"issue":"2","key":"3_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1300874","volume":"369","author":"F Lo-Coco","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih HR, Cazzola M, Melillo L, Carella AM, Brandts CH, Morra E, von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lubbert M, Hanel M, Schmitz N, Link H, Kropp MG, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Finizio O, Venditti A, Fabbiano F, Dohner K, Sauer M, Ganser A, Amadori S, Mandelli F, Dohner H, Ehninger G, Schlenk RF, Platzbecker U, Gruppo Italiano Malattie Ematologiche dA, German-Austrian Acute Myeloid Leukemia Study G, Study Alliance L (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 369(2):111\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa1300874","journal-title":"N Engl J Med"},{"issue":"23","key":"3_CR7","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.1093\/emboj\/20.23.6836","volume":"20","author":"H Nakajima","year":"2001","unstructured":"Nakajima H, Brindle PK, Handa M, Ihle JN (2001) Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription. EMBO J 20(23):6836\u20136844. https:\/\/doi.org\/10.1093\/emboj\/20.23.6836","journal-title":"EMBO J"},{"issue":"8","key":"3_CR8","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1182\/blood.v99.8.2647","volume":"99","author":"AB Maurer","year":"2002","unstructured":"Maurer AB, Wichmann C, Gross A, Kunkel H, Heinzel T, Ruthardt M, Groner B, Grez M (2002) The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complex. Blood 99(8):2647\u20132652. https:\/\/doi.org\/10.1182\/blood.v99.8.2647","journal-title":"Blood"},{"issue":"8","key":"3_CR9","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1182\/blood.v99.8.2637","volume":"99","author":"S Dong","year":"2002","unstructured":"Dong S, Tweardy DJ (2002) Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways. Blood 99(8):2637\u20132646. https:\/\/doi.org\/10.1182\/blood.v99.8.2637","journal-title":"Blood"},{"issue":"2","key":"3_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/leu.2010.276","volume":"25","author":"A Quintas-Cardama","year":"2011","unstructured":"Quintas-Cardama A, Santos FP, Garcia-Manero G (2011) Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia. Leukemia 25(2):226\u2013235. https:\/\/doi.org\/10.1038\/leu.2010.276","journal-title":"Leukemia"},{"issue":"16","key":"3_CR11","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1158\/1078-0432.CCR-19-0171","volume":"25","author":"MJ Wieduwilt","year":"2019","unstructured":"Wieduwilt MJ, Pawlowska N, Thomas S, Olin R, Logan AC, Damon LE, Martin T, Kang M, Sayre PH, Boyer W, Gaensler KML, Anderson K, Munster PN, Andreadis C (2019) Histone deacetylase inhibition with panobinostat combined with intensive induction chemotherapy in older patients with acute myeloid leukemia: phase I study results. Clin Cancer Res 25(16):4917\u20134923. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0171","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1182\/bloodadvances.2018027409","volume":"3","author":"G Garcia-Manero","year":"2019","unstructured":"Garcia-Manero G, Abaza Y, Takahashi K, Medeiros BC, Arellano M, Khaled SK, Patnaik M, Odenike O, Sayar H, Tummala M, Patel P, Maness-Harris L, Stuart R, Traer E, Karamlou K, Yacoub A, Ghalie R, Giorgino R, Atallah E (2019) Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study. Blood Adv 3(4):508\u2013518. https:\/\/doi.org\/10.1182\/bloodadvances.2018027409","journal-title":"Blood Adv"},{"issue":"11","key":"3_CR13","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.3324\/haematol.2018.201343","volume":"104","author":"X Li","year":"2019","unstructured":"Li X, Su Y, Madlambayan G, Edwards H, Polin L, Kushner J, Dzinic SH, White K, Ma J, Knight T, Wang G, Wang Y, Yang J, Taub JW, Lin H, Ge Y (2019) Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia. Haematologica 104(11):2225\u20132240. https:\/\/doi.org\/10.3324\/haematol.2018.201343","journal-title":"Haematologica"},{"issue":"1","key":"3_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/spmg.19885","volume":"2","author":"G Kaur","year":"2012","unstructured":"Kaur G, Dufour JM (2012) Cell lines: valuable tools or useless artifacts. Spermatogenesis 2(1):1\u20135. https:\/\/doi.org\/10.4161\/spmg.19885","journal-title":"Spermatogenesis"},{"issue":"8","key":"3_CR15","doi-asserted-by":"publisher","first-page":"e12464","DOI":"10.1371\/journal.pone.0012464","volume":"5","author":"AM Abdul-Nabi","year":"2010","unstructured":"Abdul-Nabi AM, Yassin ER, Varghese N, Deshmukh H, Yaseen NR (2010) In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: early gene expression profiling reveals possible drug target in AML. PLoS One 5(8):e12464. https:\/\/doi.org\/10.1371\/journal.pone.0012464","journal-title":"PLoS One"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fgene.2013.00254","volume":"4","author":"F Faridi","year":"2013","unstructured":"Faridi F, Ponnusamy K, Quagliano-Lo Coco I, Chen-Wichmann L, Grez M, Henschler R, Wichmann C (2013) Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem\/progenitor cells. Front Genet 4:254. https:\/\/doi.org\/10.3389\/fgene.2013.00254","journal-title":"Front Genet"},{"issue":"9","key":"3_CR17","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1128\/MCB.20.9.3274-3285.2000","volume":"20","author":"KR Calvo","year":"2000","unstructured":"Calvo KR, Sykes DB, Pasillas M, Kamps MP (2000) Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol Cell Biol 20(9):3274\u20133285. https:\/\/doi.org\/10.1128\/MCB.20.9.3274-3285.2000","journal-title":"Mol Cell Biol"},{"issue":"8","key":"3_CR18","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1634\/stemcells.2006-0742","volume":"25","author":"XB Zhang","year":"2007","unstructured":"Zhang XB, Schwartz JL, Humphries RK, Kiem HP (2007) Effects of HOXB4 overexpression on ex vivo expansion and immortalization of hematopoietic cells from different species. Stem Cells 25(8):2074\u20132081. https:\/\/doi.org\/10.1634\/stemcells.2006-0742","journal-title":"Stem Cells"},{"issue":"13","key":"3_CR19","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4161\/cbt.8.13.8924","volume":"8","author":"H Liu","year":"2009","unstructured":"Liu H, Cheng EH, Hsieh JJ (2009) MLL fusions: pathways to leukemia. Cancer Biol Ther 8(13):1204\u20131211. https:\/\/doi.org\/10.4161\/cbt.8.13.8924","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"3_CR20","doi-asserted-by":"publisher","first-page":"e955330","DOI":"10.1080\/23723548.2014.955330","volume":"1","author":"E Ballabio","year":"2014","unstructured":"Ballabio E, Milne TA (2014) Epigenetic control of gene expression in leukemogenesis: cooperation between wild type MLL and MLL fusion proteins. Mol Cell Oncol 1(2):e955330. https:\/\/doi.org\/10.1080\/23723548.2014.955330","journal-title":"Mol Cell Oncol"},{"issue":"6","key":"3_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrc3929","volume":"15","author":"RC Rao","year":"2015","unstructured":"Rao RC, Dou Y (2015) Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer 15(6):334\u2013346. https:\/\/doi.org\/10.1038\/nrc3929","journal-title":"Nat Rev Cancer"},{"issue":"36","key":"3_CR22","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1038\/s41388-020-01408-7","volume":"39","author":"M Ge","year":"2020","unstructured":"Ge M, Li D, Qiao Z, Sun Y, Kang T, Zhu S, Wang S, Xiao H, Zhao C, Shen S, Xu Z, Liu H (2020) Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors. Oncogene 39(36):5888\u20135901. https:\/\/doi.org\/10.1038\/s41388-020-01408-7","journal-title":"Oncogene"},{"issue":"8","key":"3_CR23","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/j.1742-4658.2010.07609.x","volume":"277","author":"MS Cosgrove","year":"2010","unstructured":"Cosgrove MS, Patel A (2010) Mixed lineage leukemia: a structure-function perspective of the MLL1 protein. FEBS J 277(8):1832\u20131842. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07609.x","journal-title":"FEBS J"},{"issue":"1","key":"3_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12185-016-2118-8","volume":"105","author":"W Yang","year":"2017","unstructured":"Yang W, Ernst P (2017) SET\/MLL family proteins in hematopoiesis and leukemia. Int J Hematol 105(1):7\u201316. https:\/\/doi.org\/10.1007\/s12185-016-2118-8","journal-title":"Int J Hematol"},{"issue":"2","key":"3_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/leu.2017.213","volume":"32","author":"C Meyer","year":"2018","unstructured":"Meyer C, Burmeister T, Groger D, Tsaur G, Fechina L, Renneville A, Sutton R, Venn NC, Emerenciano M, Pombo-de-Oliveira MS, Barbieri Blunck C, Almeida Lopes B, Zuna J, Trka J, Ballerini P, Lapillonne H, De Braekeleer M, Cazzaniga G, Corral Abascal L, van der Velden VHJ, Delabesse E, Park TS, Oh SH, Silva MLM, Lund-Aho T, Juvonen V, Moore AS, Heidenreich O, Vormoor J, Zerkalenkova E, Olshanskaya Y, Bueno C, Menendez P, Teigler-Schlegel A, Zur Stadt U, Lentes J, Gohring G, Kustanovich A, Aleinikova O, Schafer BW, Kubetzko S, Madsen HO, Gruhn B, Duarte X, Gameiro P, Lippert E, Bidet A, Cayuela JM, Clappier E, Alonso CN, Zwaan CM, van den Heuvel-Eibrink MM, Izraeli S, Trakhtenbrot L, Archer P, Hancock J, Moricke A, Alten J, Schrappe M, Stanulla M, Strehl S, Attarbaschi A, Dworzak M, Haas OA, Panzer-Grumayer R, Sedek L, Szczepanski T, Caye A, Suarez L, Cave H, Marschalek R (2018) The MLL recombinome of acute leukemias in 2017. Leukemia 32(2):273\u2013284. https:\/\/doi.org\/10.1038\/leu.2017.213","journal-title":"Leukemia"},{"issue":"24","key":"3_CR26","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1182\/blood-2008-12-197061","volume":"113","author":"M Liedtke","year":"2009","unstructured":"Liedtke M, Cleary ML (2009) Therapeutic targeting of MLL. Blood 113(24):6061\u20136068. https:\/\/doi.org\/10.1182\/blood-2008-12-197061","journal-title":"Blood"},{"issue":"37","key":"3_CR27","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","volume":"26","author":"MA Glozak","year":"2007","unstructured":"Glozak MA, Seto E (2007) Histone deacetylases and cancer. Oncogene 26(37):5420\u20135432. https:\/\/doi.org\/10.1038\/sj.onc.1210610","journal-title":"Oncogene"},{"issue":"1","key":"3_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13148-019-0723-0","volume":"11","author":"J Ye","year":"2019","unstructured":"Ye J, Zha J, Shi Y, Li Y, Yuan D, Chen Q, Lin F, Fang Z, Yu Y, Dai Y, Xu B (2019) Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. Clin Epigenetics 11(1):137. https:\/\/doi.org\/10.1186\/s13148-019-0723-0","journal-title":"Clin Epigenetics"},{"issue":"14","key":"3_CR29","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1073\/pnas.1436338100","volume":"100","author":"ZB Xia","year":"2003","unstructured":"Xia ZB, Anderson M, Diaz MO, Zeleznik-Le NJ (2003) MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci U S A 100(14):8342\u20138347. https:\/\/doi.org\/10.1073\/pnas.1436338100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1038\/oncsis.2014.39","volume":"3","author":"K Ahmad","year":"2014","unstructured":"Ahmad K, Katryniok C, Scholz B, Merkens J, Loscher D, Marschalek R, Steinhilber D (2014) Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL. Oncogene 3:e127. https:\/\/doi.org\/10.1038\/oncsis.2014.39","journal-title":"Oncogene"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fcell.2019.00081","volume":"7","author":"AKN Chan","year":"2019","unstructured":"Chan AKN, Chen CW (2019) Rewiring the epigenetic networks in MLL-rearranged leukemias: epigenetic dysregulation and pharmacological interventions. Front Cell Dev Biol 7:81. https:\/\/doi.org\/10.3389\/fcell.2019.00081","journal-title":"Front Cell Dev Biol"},{"issue":"40","key":"3_CR32","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1038\/onc.2016.30","volume":"35","author":"RK Slany","year":"2016","unstructured":"Slany RK (2016) The molecular mechanics of mixed lineage leukemia. Oncogene 35(40):5215\u20135223. https:\/\/doi.org\/10.1038\/onc.2016.30","journal-title":"Oncogene"},{"issue":"16","key":"3_CR33","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1182\/blood-2016-10-691428","volume":"129","author":"TA Milne","year":"2017","unstructured":"Milne TA (2017) Mouse models of MLL leukemia: recapitulating the human disease. Blood 129(16):2217\u20132223. https:\/\/doi.org\/10.1182\/blood-2016-10-691428","journal-title":"Blood"},{"issue":"7","key":"3_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1182\/blood-2017-04-777185","volume":"130","author":"S Lin","year":"2017","unstructured":"Lin S, Luo RT, Shrestha M, Thirman MJ, Mulloy JC (2017) The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment. Blood 130(7):903\u2013907. https:\/\/doi.org\/10.1182\/blood-2017-04-777185","journal-title":"Blood"},{"issue":"5824","key":"3_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1139851","volume":"316","author":"F Barabe","year":"2007","unstructured":"Barabe F, Kennedy JA, Hope KJ, Dick JE (2007) Modeling the initiation and progression of human acute leukemia in mice. Science 316(5824):600\u2013604. https:\/\/doi.org\/10.1126\/science.1139851","journal-title":"Science"},{"issue":"9","key":"3_CR36","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3324\/haematol.2017.164046","volume":"102","author":"J Reimer","year":"2017","unstructured":"Reimer J, Knoss S, Labuhn M, Charpentier EM, Gohring G, Schlegelberger B, Klusmann JH, Heckl D (2017) CRISPR-Cas9-induced t(11;19)\/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo. Haematologica 102(9):1558\u20131566. https:\/\/doi.org\/10.3324\/haematol.2017.164046","journal-title":"Haematologica"},{"issue":"14","key":"3_CR37","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1182\/blood-2015-05-646398","volume":"126","author":"C Buechele","year":"2015","unstructured":"Buechele C, Breese EH, Schneidawind D, Lin CH, Jeong J, Duque-Afonso J, Wong SH, Smith KS, Negrin RS, Porteus M, Cleary ML (2015) MLL leukemia induction by genome editing of human CD34+ hematopoietic cells. Blood 126(14):1683\u20131694. https:\/\/doi.org\/10.1182\/blood-2015-05-646398","journal-title":"Blood"},{"issue":"15","key":"3_CR38","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2016-12-689109","volume":"129","author":"M de Bruijn","year":"2017","unstructured":"de Bruijn M, Dzierzak E (2017) Runx transcription factors in the development and function of the definitive hematopoietic system. Blood 129(15):2061\u20132069. https:\/\/doi.org\/10.1182\/blood-2016-12-689109","journal-title":"Blood"},{"issue":"13","key":"3_CR39","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.1074\/jbc.M010582200","volume":"276","author":"D Hildebrand","year":"2001","unstructured":"Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB (2001) Multiple regions of ETO cooperate in transcriptional repression. J Biol Chem 276(13):9889\u20139895. https:\/\/doi.org\/10.1074\/jbc.M010582200","journal-title":"J Biol Chem"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0378-1119(02)01172-1","volume":"303","author":"JN Davis","year":"2003","unstructured":"Davis JN, McGhee L, Meyers S (2003) The ETO (MTG8) gene family. Gene 303:1\u201310. https:\/\/doi.org\/10.1016\/s0378-1119(02)01172-1","journal-title":"Gene"},{"issue":"1","key":"3_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1182\/bloodadvances.2019000168","volume":"4","author":"S Al-Harbi","year":"2020","unstructured":"Al-Harbi S, Aljurf M, Mohty M, Almohareb F, Ahmed SOA (2020) An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1. Blood Adv 4(1):229\u2013238. https:\/\/doi.org\/10.1182\/bloodadvances.2019000168","journal-title":"Blood Adv"},{"issue":"15","key":"3_CR42","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","volume":"129","author":"R Sood","year":"2017","unstructured":"Sood R, Kamikubo Y, Liu P (2017) Role of RUNX1 in hematological malignancies. Blood 129(15):2070\u20132082. https:\/\/doi.org\/10.1182\/blood-2016-10-687830","journal-title":"Blood"},{"issue":"1","key":"3_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1182\/blood.v99.1.15","volume":"99","author":"JC Mulloy","year":"2002","unstructured":"Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MA, Nimer SD (2002) The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood 99(1):15\u201323. https:\/\/doi.org\/10.1182\/blood.v99.1.15","journal-title":"Blood"},{"issue":"13","key":"3_CR44","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1182\/blood-2003-05-1762","volume":"102","author":"JC Mulloy","year":"2003","unstructured":"Mulloy JC, Cammenga J, Berguido FJ, Wu K, Zhou P, Comenzo RL, Jhanwar S, Moore MA, Nimer SD (2003) Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood 102(13):4369\u20134376. https:\/\/doi.org\/10.1182\/blood-2003-05-1762","journal-title":"Blood"},{"issue":"2","key":"3_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/leu.2014.179","volume":"29","author":"C Wichmann","year":"2015","unstructured":"Wichmann C, Quagliano-Lo Coco I, Yildiz O, Chen-Wichmann L, Weber H, Syzonenko T, Doring C, Brendel C, Ponnusamy K, Kinner A, Brandts C, Henschler R, Grez M (2015) Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1\/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors. Leukemia 29(2):279\u2013289. https:\/\/doi.org\/10.1038\/leu.2014.179","journal-title":"Leukemia"},{"key":"3_CR46","doi-asserted-by":"publisher","first-page":"11733","DOI":"10.1038\/ncomms11733","volume":"7","author":"L Hartmann","year":"2016","unstructured":"Hartmann L, Dutta S, Opatz S, Vosberg S, Reiter K, Leubolt G, Metzeler KH, Herold T, Bamopoulos SA, Braundl K, Zellmeier E, Ksienzyk B, Konstandin NP, Schneider S, Hopfner KP, Graf A, Krebs S, Blum H, Middeke JM, Stolzel F, Thiede C, Wolf S, Bohlander SK, Preiss C, Chen-Wichmann L, Wichmann C, Sauerland MC, Buchner T, Berdel WE, Wormann BJ, Braess J, Hiddemann W, Spiekermann K, Greif PA (2016) ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation. Nat Commun 7:11733. https:\/\/doi.org\/10.1038\/ncomms11733","journal-title":"Nat Commun"},{"issue":"15","key":"3_CR47","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1038\/s41388-020-1209-4","volume":"39","author":"E Redondo Monte","year":"2020","unstructured":"Redondo Monte E, Wilding A, Leubolt G, Kerbs P, Bagnoli JW, Hartmann L, Hiddemann W, Chen-Wichmann L, Krebs S, Blum H, Cusan M, Vick B, Jeremias I, Enard W, Theurich S, Wichmann C, Greif PA (2020) ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells. Oncogene 39(15):3195\u20133205. https:\/\/doi.org\/10.1038\/s41388-020-1209-4","journal-title":"Oncogene"},{"issue":"12","key":"3_CR48","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1128\/MCB.18.12.7176","volume":"18","author":"B Lutterbach","year":"1998","unstructured":"Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW (1998) ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18(12):7176\u20137184. https:\/\/doi.org\/10.1128\/MCB.18.12.7176","journal-title":"Mol Cell Biol"},{"issue":"4","key":"3_CR49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1182\/blood-2009-10-248047","volume":"116","author":"C Wichmann","year":"2010","unstructured":"Wichmann C, Becker Y, Chen-Wichmann L, Vogel V, Vojtkova A, Herglotz J, Moore S, Koch J, Lausen J, Mantele W, Gohlke H, Grez M (2010) Dimer-tetramer transition controls RUNX1\/ETO leukemogenic activity. Blood 116(4):603\u2013613. https:\/\/doi.org\/10.1182\/blood-2009-10-248047","journal-title":"Blood"},{"issue":"2","key":"3_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41388-018-0441-7","volume":"38","author":"L Chen-Wichmann","year":"2019","unstructured":"Chen-Wichmann L, Shvartsman M, Preiss C, Hockings C, Windisch R, Redondo Monte E, Leubolt G, Spiekermann K, Lausen J, Brendel C, Grez M, Greif PA, Wichmann C (2019) Compatibility of RUNX1\/ETO fusion protein modules driving CD34+ human progenitor cell expansion. Oncogene 38(2):261\u2013272. https:\/\/doi.org\/10.1038\/s41388-018-0441-7","journal-title":"Oncogene"},{"issue":"14","key":"3_CR51","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/sj.gt.3301970","volume":"10","author":"L Shi","year":"2003","unstructured":"Shi L, Tang GP, Gao SJ, Ma YX, Liu BH, Li Y, Zeng JM, Ng YK, Leong KW, Wang S (2003) Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord. Gene Ther 10(14):1179\u20131188. https:\/\/doi.org\/10.1038\/sj.gt.3301970","journal-title":"Gene Ther"},{"issue":"5","key":"3_CR52","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1128\/mcb.8.5.2159-2165.1988","volume":"8","author":"J Field","year":"1988","unstructured":"Field J, Nikawa J, Broek D, MacDonald B, Rodgers L, Wilson IA, Lerner RA, Wigler M (1988) Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol 8(5):2159\u20132165. https:\/\/doi.org\/10.1128\/mcb.8.5.2159-2165.1988","journal-title":"Mol Cell Biol"},{"issue":"1","key":"3_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1128\/MCB.21.1.156-163.2001","volume":"21","author":"J Zhang","year":"2001","unstructured":"Zhang J, Hug BA, Huang EY, Chen CW, Gelmetti V, Maccarana M, Minucci S, Pelicci PG, Lazar MA (2001) Oligomerization of ETO is obligatory for corepressor interaction. Mol Cell Biol 21(1):156\u2013163. https:\/\/doi.org\/10.1128\/MCB.21.1.156-163.2001","journal-title":"Mol Cell Biol"},{"issue":"8","key":"3_CR54","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.celrep.2016.08.082","volume":"17","author":"A Mandoli","year":"2016","unstructured":"Mandoli A, Singh AA, Prange KHM, Tijchon E, Oerlemans M, Dirks R, Ter Huurne M, Wierenga ATJ, Janssen-Megens EM, Berentsen K, Sharifi N, Kim B, Matarese F, Nguyen LN, Hubner NC, Rao NA, van den Akker E, Altucci L, Vellenga E, Stunnenberg HG, Martens JHA (2016) The hematopoietic transcription factors RUNX1 and ERG prevent AML1-ETO oncogene overexpression and onset of the apoptosis program in t(8;21) AMLs. Cell Rep 17(8):2087\u20132100. https:\/\/doi.org\/10.1016\/j.celrep.2016.08.082","journal-title":"Cell Rep"},{"issue":"3","key":"3_CR55","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1182\/bloodadvances.2018024422","volume":"3","author":"M Gerritsen","year":"2019","unstructured":"Gerritsen M, Yi G, Tijchon E, Kuster J, Schuringa JJ, Martens JHA, Vellenga E (2019) RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs. Blood Adv 3(3):320\u2013332. https:\/\/doi.org\/10.1182\/bloodadvances.2018024422","journal-title":"Blood Adv"},{"issue":"5","key":"3_CR56","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1182\/blood-2005-12-012773","volume":"108","author":"M Wunderlich","year":"2006","unstructured":"Wunderlich M, Krejci O, Wei J, Mulloy JC (2006) Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability. Blood 108(5):1690\u20131697. https:\/\/doi.org\/10.1182\/blood-2005-12-012773","journal-title":"Blood"},{"issue":"6","key":"3_CR57","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","volume":"13","author":"J Wei","year":"2008","unstructured":"Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, Wilhelm JS, Zheng Y, Cancelas JA, Gu Y, Jansen M, Dimartino JF, Mulloy JC (2008) Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell 13(6):483\u2013495. https:\/\/doi.org\/10.1016\/j.ccr.2008.04.020","journal-title":"Cancer Cell"},{"issue":"18","key":"3_CR58","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1182\/blood-2010-12-322230","volume":"117","author":"R Montes","year":"2011","unstructured":"Montes R, Ayllon V, Gutierrez-Aranda I, Prat I, Hernandez-Lamas MC, Ponce L, Bresolin S, Te Kronnie G, Greaves M, Bueno C, Menendez P (2011) Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia. Blood 117(18):4746\u20134758. https:\/\/doi.org\/10.1182\/blood-2010-12-322230","journal-title":"Blood"},{"issue":"24","key":"3_CR59","doi-asserted-by":"publisher","first-page":"11781","DOI":"10.1158\/0008-5472.CAN-06-0706","volume":"66","author":"KY Chung","year":"2006","unstructured":"Chung KY, Morrone G, Schuringa JJ, Plasilova M, Shieh JH, Zhang Y, Zhou P, Moore MA (2006) Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation. Cancer Res 66(24):11781\u201311791. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0706","journal-title":"Cancer Res"},{"issue":"22","key":"3_CR60","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","volume":"116","author":"A Rizo","year":"2010","unstructured":"Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R, van den Boom V, Vellenga E, de Haan G, Schuringa JJ (2010) BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Blood 116(22):4621\u20134630. https:\/\/doi.org\/10.1182\/blood-2010-02-270660","journal-title":"Blood"}],"container-title":["Methods in Molecular Biology","HDAC\/HAT Function Assessment and Inhibitor Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2788-4_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T13:05:28Z","timestamp":1666098328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2788-4_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"ISBN":["9781071627877","9781071627884"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2788-4_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"19 October 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}